Live Breaking News & Updates on Artiva allo

Stay informed with the latest breaking news from Artiva allo on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Artiva allo and stay connected to the pulse of your community

Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology

The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been...

United-states , Ukraine , Texas , Germany , Mannheim , Baden-wüberg , American , Mary-beth-sandin , Hye-ryun-kim , Alexander-fudukidis , Artiva-allo , American-society-of-clinical-oncology

Affimed N.V.: Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology

Affimed N.V.: Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Mannheim , Baden-wüberg , Germany , Ukraine , Russia , Texas , American , Alexander-fudukidis , Hye-ryun-kim , Artiva-allo , Dennis-riedl

Affimed Reports 2023 Financial Results and Operational

AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer...

Germany , Russia , Ukraine , Texas , United-states , Mannheim , Baden-wüberg , Andreas-harstrick , Artiva-allo , Alexander-fudukidis , University-of-texas-md-anderson-cancer-center , Genentech

Innate cell engagers for lymphoma treatment

Innate cell engagers for lymphoma treatment
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Germany , Hannover , Niedersachsen , Merck-serono , Eli-lilly , Andreas-harstrick , Artiva-allo , Sciences-at-imclone-systems-inc , Md-anderson-cancer-center , Artiva-inc , Hannover-medical-school , Drug-administration

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Germany , San-diego , California , Russia , New-york , Mannheim , Baden-wüberg , Ukraine , American , Yago-nieto

Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients

Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Germany , Texas , United-states , Mannheim , Baden-wüberg , New-york , Russia , Ukraine , Alexander-fudukidis , Mary-beth-sandin , Andreas-harstrick , Artiva-allo

Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , Ukraine , Texas , United-states , New-york , Russia , Mannheim , Baden-wüberg , American , Alexander-fudukidisdirector , Artiva-allo , Adi-hoess

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mannheim , Baden-wüberg , Germany , New-york , United-states , Texas , San-diego , California , Ukraine , Russia , Contactjessica-yingling , Mary-beth-sandin

Affimed (AFMD) Granted FDA Fast Track Designation for AFM13 in Combination with AlloNK

Affimed (AFMD) Granted FDA Fast Track Designation for AFM13 in Combination with AlloNK
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mannheim , Baden-wüberg , Germany , New-york , United-states , Ukraine , Texas , San-diego , California , Russia , Wolfgang-fischer , Artiva-biotherapeutics

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the ...

AFM13 in combination with AlloNK® (also known as AB-101) will be investigated in the LuminICE-203 open-label, multi-center, multi-cohort, phase 2 study evaluating the efficacy and safety of the treatment in

Mannheim , Baden-wüberg , Germany , New-york , United-states , Ukraine , Russia , San-diego , California , Texas , Nicholas-veomett , Alexander-fudukidis